Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 1Neurofibroma 1

Interventions

Educational Status 5Interviews as Topic 4Methods 3Magnetic Resonance Imaging 3Early Intervention, Educational 3Cisplatin 3Blood Specimen Collection 3pembrolizumab 2Standard of Care 2Nivolumab 2Music Therapy 2Gemcitabine 2Counseling 2zilucoplan 1tislelizumab 1somapacitan 1sacituzumab govitecan 1rozanolixizumab 1oxycodone-acetaminophen 1ibrutinib 1futibatinib 1fluorodopa F 18 1erdafitinib 1enzalutamide 1enfortumab vedotin 1dynorphin-converting endopeptidase 1durvalumab 1dalpiciclib 1brexucabtagene autoleucel 1axicabtagene ciloleucel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Deoxycholic Acid × 90 days × Clear all
NCT06300502 2026-04-22

Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)

Massachusetts General Hospital

Phase 1 Enrolling by invitation
15 enrolled
CNS

Neurofibroma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡